Published in Eur J Clin Pharmacol on October 03, 2013
Secondary Prevention of Dug-related Problems Through Digital Health | NCT04841863
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA (1998) 32.05
The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med (1991) 26.50
Adverse events in British hospitals: preliminary retrospective record review. BMJ (2001) 23.99
The Quality in Australian Health Care Study. Med J Aust (1995) 22.93
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ (2004) 21.24
Medication errors and adverse drug events in pediatric inpatients. JAMA (2001) 11.34
The incidence and nature of in-hospital adverse events: a systematic review. Qual Saf Health Care (2008) 6.79
National surveillance of emergency department visits for outpatient adverse drug events. JAMA (2006) 6.24
Adverse events in New Zealand public hospitals I: occurrence and impact. N Z Med J (2002) 5.99
Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med (2008) 4.79
[Incidence of adverse events in hospitals. A retrospective study of medical records]. Ugeskr Laeger (2001) 4.62
Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. CMAJ (2008) 3.24
Costs of medical injuries in Utah and Colorado. Inquiry (1999) 3.23
Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med (2007) 3.11
Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ (2009) 2.10
Drug interactions with smoking. Am J Health Syst Pharm (2007) 1.49
Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol (1999) 1.47
Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol (2007) 1.46
Terms used in patient safety related to medication: a literature review. Pharmacoepidemiol Drug Saf (2012) 1.42
From "drug-related problems" to "negative clinical outcomes". Am J Health Syst Pharm (2005) 1.39
Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf (2008) 1.31
National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr (2007) 1.31
Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. J Epidemiol Community Health (2008) 1.25
Emergency physician recognition of adverse drug-related events in elder patients presenting to an emergency department. Acad Emerg Med (2005) 1.17
French national survey of inpatient adverse events prospectively assessed with ward staff. Qual Saf Health Care (2007) 1.14
Characterization of drug-related problems in elderly patients on admission to a medical ward. Can J Hosp Pharm (1995) 1.08
Emergency department visits caused by adverse drug events: results of a French survey. Drug Saf (2007) 1.05
Emergency department visits for outpatient adverse drug events: demonstration for a national surveillance system. Ann Emerg Med (2005) 1.01
Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol (2006) 0.98
Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepidemiol Drug Saf (2005) 0.97
Reliability of the assessment of preventable adverse drug events in daily clinical practice. Pharmacoepidemiol Drug Saf (2008) 0.93
Drug-related visits to a district hospital emergency room. Basic Clin Pharmacol Toxicol (2006) 0.90
Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial. J Manag Care Pharm (2012) 0.87
Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Card Fail (2010) 0.86
[Incidence rate of adverse drug effects in a hospital emergency unit and its associated factors]. Farm Hosp (2010) 0.78
[Negative results associated with medication in the emergency department of a hospital]. Farm Hosp (2008) 0.78
The burden and risk factors for adverse drug events in older patients--a prospective cross-sectional study. S Afr Med J (2006) 0.78
Morbidity and mortality associated with pharmacotherapy. Evolution and current concept of drug-related problems. Curr Pharm Des (2004) 0.77
The biochemistry of drug metabolism--an introduction: part 7. Intra-individual factors affecting drug metabolism. Chem Biodivers (2009) 0.76
Reversible Ponceau staining as a loading control alternative to actin in Western blots. Anal Biochem (2010) 2.63
Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol (2008) 2.04
In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol (2005) 1.97
Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem (2007) 1.89
Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) (2008) 1.80
Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens (2006) 1.79
Protective effects of the flavonoid quercetin in chronic nitric oxide deficient rats. J Hypertens (2002) 1.57
Effects of dietary fiber on inflammatory bowel disease. Mol Nutr Food Res (2005) 1.51
Terms used in patient safety related to medication: a literature review. Pharmacoepidemiol Drug Saf (2012) 1.42
Evaluation of the preventative effects exerted by Lactobacillus fermentum in an experimental model of septic shock induced in mice. Br J Nutr (2008) 1.42
The effects of short-chain fatty acids on colon epithelial proliferation and survival depend on the cellular phenotype. J Cancer Res Clin Oncol (2006) 1.36
Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochem Pharmacol (2006) 1.34
Molecular bases of impaired water and ion movements in inflammatory bowel diseases. Inflamm Bowel Dis (2009) 1.20
Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr (2005) 1.18
Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur J Nutr (2006) 1.14
Anti-inflammatory effect of diosmectite in hapten-induced colitis in the rat. Br J Pharmacol (2004) 1.13
Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol (2005) 1.12
Quercetin inhibits vascular superoxide production induced by endothelin-1: Role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis (2008) 1.08
The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol (2004) 1.07
Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr (2002) 1.01
Effect of a pharmacist intervention on asthma control. A cluster randomised trial. Respir Med (2013) 1.00
Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis (2005) 0.99
Medicine-related problems resulting in emergency department visits. Eur J Clin Pharmacol (2006) 0.98
A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr (2007) 0.98
Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. J Nutr (2006) 0.98
Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension (2008) 0.96
Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis (2005) 0.94
Active hexose correlated compound acts as a prebiotic and is antiinflammatory in rats with hapten-induced colitis. J Nutr (2007) 0.94
Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem Pharmacol (2004) 0.93
The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. Biochem Pharmacol (2011) 0.93
Chronic administration of genistein improves endothelial dysfunction in spontaneously hypertensive rats: involvement of eNOS, caveolin and calmodulin expression and NADPH oxidase activity. Clin Sci (Lond) (2007) 0.92
Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology (2010) 0.92
Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic Biol Med (2007) 0.92
Intestinal anti-inflammatory activity of paepalantine, an isocoumarin isolated from the capitula of Paepalanthus bromelioides, in the trinitrobenzenesulphonic acid model of rat colitis. Planta Med (2004) 0.92
Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats. Hypertension (2011) 0.91
Prebiotic oligosaccharides directly modulate proinflammatory cytokine production in monocytes via activation of TLR4. Mol Nutr Food Res (2013) 0.91
Effects of chronic quercetin treatment in experimental renovascular hypertension. Mol Cell Biochem (2005) 0.90
Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway. J Pharmacol Exp Ther (2009) 0.90
The intestinal antiinflammatory agent glycomacropeptide has immunomodulatory actions on rat splenocytes. Biochem Pharmacol (2010) 0.90
Nondigestible oligosaccharides exert nonprebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4-NFκB. Mol Nutr Food Res (2013) 0.89
Tissue-nonspecific alkaline phosphatase is activated in enterocytes by oxidative stress via changes in glycosylation. Inflamm Bowel Dis (2011) 0.89
Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study. Res Social Adm Pharm (2013) 0.89
Bovine glycomacropeptide has intestinal antiinflammatory effects in rats with dextran sulfate-induced colitis. J Nutr (2010) 0.89
Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis. J Nutr (2005) 0.88
Disturbances in metabolic, transport and structural genes in experimental colonic inflammation in the rat: a longitudinal genomic analysis. BMC Genomics (2008) 0.88
Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Mol Cell Biochem (2004) 0.88
The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. Inflamm Bowel Dis (2003) 0.88
Agreement between community pharmacy, physician's office, and home blood pressure measurement methods: the PALMERA Study. Am J Hypertens (2011) 0.87
Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol (2010) 0.87
Disturbances in epithelial ionic secretion in different experimental models of colitis. Life Sci (2004) 0.86
The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties. Pharmacol Res (2010) 0.85
The combination of fructooligosaccharides and resistant starch shows prebiotic additive effects in rats. Clin Nutr (2010) 0.85
Intestinal anti-inflammatory activity of hydroalcoholic extracts of Phlomis purpurea L. and Phlomis lychnitis L. in the trinitrobenzenesulphonic acid model of rat colitis. J Ethnopharmacol (2013) 0.84
A shorter and more specific oral sensitization-based experimental model of food allergy in mice. J Immunol Methods (2012) 0.84
Plantago ovata husks-supplemented diet ameliorates metabolic alterations in obese Zucker rats through activation of AMP-activated protein kinase. Comparative study with other dietary fibers. Clin Nutr (2009) 0.83
Soy isoflavones improve endothelial function in spontaneously hypertensive rats in an estrogen-independent manner: role of nitric-oxide synthase, superoxide, and cyclooxygenase metabolites. J Pharmacol Exp Ther (2005) 0.83
Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis. Int Immunopharmacol (2012) 0.83
Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. Eur J Pharmacol (2009) 0.83
Effects of chronic chrysin treatment in spontaneously hypertensive rats. Planta Med (2002) 0.83
Effect of flavonoids on rat splenocytes, a structure-activity relationship study. Biochem Pharmacol (2008) 0.82
Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-kappaB signal transduction pathways. Br J Pharmacol (2009) 0.82
UR-1505, a new salicylate, blocks T cell activation through nuclear factor of activated T cells. Mol Pharmacol (2007) 0.82
Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats. Comparative study with verapamil. Planta Med (2004) 0.81
Endothelial nitric oxide production stimulated by the bioflavonoid chrysin in rat isolated aorta. Planta Med (2005) 0.81
Intestinal anti-inflammatory effects of oligosaccharides derived from lactulose in the trinitrobenzenesulfonic acid model of rat colitis. J Agric Food Chem (2014) 0.81
New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. Proc Nutr Soc (2010) 0.81
Comparison of the white-coat effect in community pharmacy versus the physician's office: the Palmera study. Blood Press Monit (2011) 0.80
Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program. Pharmacoeconomics (2015) 0.80
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation. Atherosclerosis (2010) 0.79
Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension. Cardiovasc Res (2013) 0.78
Impact of implementing smart infusion pumps in a pediatric intensive care unit. Am J Health Syst Pharm (2013) 0.78
The nutritional supplement Active Hexose Correlated Compound (AHCC) has direct immunomodulatory actions on intestinal epithelial cells and macrophages involving TLR/MyD88 and NF-κB/MAPK activation. Food Chem (2012) 0.78
Di-D-fructose dianhydride-enriched caramels: effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic rats. J Agric Food Chem (2010) 0.78
Effects of the dietary flavonoid chrysin in isolated rat mesenteric vascular bed. J Vasc Res (2004) 0.78
Cardiogenic shock in acute coronary syndrome in the Spanish population. Med Sci Monit (2008) 0.78
[Priorization of facilitators for the implementation of medication review with follow-up service in Spanish community pharmacies through exploratory factor analysis]. Aten Primaria (2013) 0.77
In vivo vascular effects of genistein on a rat model of septic shock induced by lipopolysaccharide. J Cardiovasc Pharmacol (2003) 0.77
The intestinal anti-inflammatory effects of the novel agent UR-1505 in the TNBS model of rat colitis are mediated by T-lymphocyte inhibition. Biochem Pharmacol (2007) 0.77
UR-1505, a salicylate able to selectively block T-cell activation, shows intestinal anti-inflammatory activity in the chronic phase of the DSS model of rat colitis. Inflamm Bowel Dis (2008) 0.77
Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats. Metabolism (2013) 0.77
Evaluation of the performance of echocardiography in acute coronary syndrome patients during their stay in coronary units. Acute Card Care (2011) 0.77
Active hexose correlated compound exerts therapeutic effects in lymphocyte driven colitis. Mol Nutr Food Res (2014) 0.77
Genistein restores caveolin-1 and AT-1 receptor expression and vascular function in large vessels of ovariectomized hypertensive rats. Menopause (2007) 0.76
Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis. Eur J Nutr (2012) 0.76
Intestinal antiinflammatory activity of a lyophilized infusion of Turnera ulmifolia in TNBS rat colitis. Fitoterapia (2006) 0.76
Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling. Pharmacogenet Genomics (2009) 0.76
The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine. Eur J Nutr (2011) 0.76
The new salicylate derivative UR-1505 modulates the Th2/humoral response in a dextran sodium sulphate model of colitis that resembles ulcerative colitis. J Pharmacol Sci (2009) 0.76
Relationship between urinary albumin excretion and blood pressure in the community pharmacy: the Palmera study. Am J Hypertens (2013) 0.75
Role of the hospital pharmacy and therapeutics committee in detecting and regulating off-label drug use. Int J Clin Pharm (2011) 0.75
Baseline glutathione peroxidase activity affects prognosis after acute coronary syndromes. Tex Heart Inst J (2008) 0.75
It may not be intestinal, but tissue non-specific alkaline phosphatase. Gut (2010) 0.75
Involvement of protein kinase C and Na+/K+-ATPase in the contractile response induced by myricetin in rat isolated aorta. Planta Med (2002) 0.75
Errors in Turbuhaler technique in a Spanish population of asthmatic patients. Respir Care (2012) 0.75
Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients. Am J Health Syst Pharm (2012) 0.75
Active colitis exacerbates immune response to internalized food antigens in mice. Int Arch Allergy Immunol (2013) 0.75
Monochloramine induces acute and protracted colitis in the rat: response to pharmacological treatment. Life Sci (2005) 0.75
Usefulness of blood pressure measurement by community pharmacists in the management of hypertension. J Manag Care Pharm (2012) 0.75